Z15.09
BillableGenetic susceptibility to other malignant neoplasm
Genetic susceptibility to other malignant neoplasm
Coding Notes
Includes
Conditions included under this code
- confirmed abnormal gene
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Code First
The underlying condition must be sequenced before this code
Use Additional Code
Additional codes that should follow this code
Related Codes(4)
Also Known As / Clinical Terms(105)
SNOMED CT
- Macroencephaly9740002
- Megalencephaly9740002
- Hereditary cancer-predisposing syndrome699346009
- Hereditary neoplastic syndrome699346009
- Mosaic variegated aneuploidy syndrome700056005
- M-CM - macrocephaly capillary malformation700063005
- MCAP - megalencephaly capillary malformation700063005
- Macrocephaly-capillary malformation700063005
- Macrocephaly-cutis marmorata telangiectatica congenita700063005
- Megalencephaly capillary malformation700063005
- Megalencephaly, capillary malformation, polymicrogyria syndrome700063005
- DICER1 syndrome702411003
- Pleuropulmonary blastoma familial tumor and dysplasia syndrome702411003
- Pleuropulmonary blastoma familial tumour and dysplasia syndrome702411003
- Pleuropulmonary blastoma family tumor susceptibility syndrome702411003
- Pleuropulmonary blastoma family tumour susceptibility syndrome702411003
- Lynch syndrome716318002
- Palmoplantar keratoderma, 46,XX sex reversal, predisposition to squamous cell carcinoma syndrome722202006
- BAP1 tumor predisposition syndrome765057007
- BAP1 tumour predisposition syndrome765057007
- BAP1-related tumor predisposition syndrome765057007
- BAP1-related tumour predisposition syndrome765057007
- BRCA1 associated protein 1 tumor predisposition syndrome765057007
- BRCA1 associated protein 1 tumour predisposition syndrome765057007
- Tumor susceptibility associated with germline BAP1 mutation765057007
- Tumour susceptibility associated with germline BAP1 mutation765057007
- Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutation766707003
- MITF (melanogenesis associated transcription factor) related melanoma and renal cell carcinoma predisposition syndrome770896003
- MITF-related melanoma and renal cell carcinoma predisposition syndrome770896003
- Melanogenesis associated transcription factor related melanoma and renal cell carcinoma predisposition syndrome770896003
- Familial rhabdoid tumor772130002
- Familial rhabdoid tumour772130002
- Rhabdoid tumor predisposition syndrome772130002
- Rhabdoid tumour predisposition syndrome772130002
- Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome782823001
- DDX41-related haematologic malignancy predisposition syndrome1172625004
- DDX41-related hematologic malignancy predisposition syndrome1172625004
- DEAD-box helicase 41-related haematologic malignancy predisposition syndrome1172625004
- DEAD-box helicase 41-related hematologic malignancy predisposition syndrome1172625004
- Combined immunodeficiency due to CARMIL2 deficiency1186712009
- Combined immunodeficiency due to RLTPR deficiency1186712009
- Combined immunodeficiency due to capping protein regulator and myosin 1 linker 2 deficiency1186712009
- Combined immunodeficiency due to CD70 deficiency1186715006
- Progeroid features, hepatocellular carcinoma predisposition syndrome1216939003
- Ruijs Aalfs syndrome1216939003
- Hereditary well-differentiated neuroendocrine tumor of small intestine1288023007
- Hereditary well-differentiated neuroendocrine tumour of small intestine1288023007
- Genetic susceptibility to cancer85121000119109
- HNPCC (hereditary non-polyposis colon cancer) gene mutation positive1099611000119109
- Hereditary non-polyposis colon cancer gene mutation detected1099611000119109
- Hereditary non-polyposis colon cancer gene mutation positive1099611000119109
- Hereditary nonpolyposis colon cancer gene mutation positive1099611000119109
Clinical Terms
- DDX41-related haematologic malignancy predisposition syndrome
- Lynch syndrome
- Hereditary well-differentiated neuroendocrine tumour of small intestine
- Hereditary non-polyposis colon cancer gene mutation detected
- Rhabdoid tumor predisposition syndrome
- Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutation
- DEAD-box helicase 41-related hematologic malignancy predisposition syndrome
- Combined immunodeficiency due to RLTPR deficiency
- Pleuropulmonary blastoma familial tumor and dysplasia syndrome
- Tumor susceptibility associated with germline BAP1 mutation
- MITF (melanogenesis associated transcription factor) related melanoma and renal cell carcinoma predisposition syndrome
- BAP1-related tumour predisposition syndrome
- BAP1 tumour predisposition syndrome
- Mosaic variegated aneuploidy syndrome
- Familial rhabdoid tumour
- Pleuropulmonary blastoma family tumour susceptibility syndrome
- Progeroid features, hepatocellular carcinoma predisposition syndrome
- BRCA1 associated protein 1 tumor predisposition syndrome
- Pleuropulmonary blastoma familial tumour and dysplasia syndrome
- Macrocephaly-capillary malformation
- Combined immunodeficiency due to CARMIL2 deficiency
- MITF-related melanoma and renal cell carcinoma predisposition syndrome
- DDX41-related hematologic malignancy predisposition syndrome
- Combined immunodeficiency due to capping protein regulator and myosin 1 linker 2 deficiency
- DEAD-box helicase 41-related haematologic malignancy predisposition syndrome
- Hereditary neoplastic syndrome
- Megalencephaly
- Rhabdoid tumour predisposition syndrome
- DICER1 syndrome
- Hereditary non-polyposis colon cancer gene mutation positive
- Hereditary well-differentiated neuroendocrine tumor of small intestine
- Genetic susceptibility to cancer
- Megalencephaly capillary malformation
- Ruijs Aalfs syndrome
- Hereditary cancer-predisposing syndrome
- Megalencephaly, capillary malformation, polymicrogyria syndrome
- Macroencephaly
- Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome
- Pleuropulmonary blastoma family tumor susceptibility syndrome
- HNPCC (hereditary non-polyposis colon cancer) gene mutation positive
- Familial rhabdoid tumor
- BRCA1 associated protein 1 tumour predisposition syndrome
- Combined immunodeficiency due to CD70 deficiency
- Tumour susceptibility associated with germline BAP1 mutation
- MCAP - megalencephaly capillary malformation
- Palmoplantar keratoderma, 46,XX sex reversal, predisposition to squamous cell carcinoma syndrome
- Melanogenesis associated transcription factor related melanoma and renal cell carcinoma predisposition syndrome
- Macrocephaly-cutis marmorata telangiectatica congenita
- BAP1-related tumor predisposition syndrome
- Hereditary nonpolyposis colon cancer gene mutation positive
- M-CM - macrocephaly capillary malformation
- BAP1 tumor predisposition syndrome
Frequently Asked Questions
What is the ICD-10 code for genetic susceptibility to other malignant neoplasm?
The ICD-10-CM code for genetic susceptibility to other malignant neoplasm is Z15.09. The full clinical description is "Genetic susceptibility to other malignant neoplasm". Z15.09 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code Z15.09 mean?
ICD-10-CM code Z15.09 represents “Genetic susceptibility to other malignant neoplasm”. It is classified under Chapter 22: Factors Influencing Health Status and Contact With Health Services and is a billable/specific code that can be used on a claim.
Is Z15.09 a billable code?
Yes, Z15.09 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is Z15.09 in?
Z15.09 is in Chapter 22: Factors Influencing Health Status and Contact With Health Services (codes Z00-Z99).
What codes cannot be used with Z15.09?
Z15.09 has Excludes1 notes indicating codes that cannot be used together with it, including: chromosomal anomalies (Q90-Q99).
Are additional codes required with Z15.09?
Yes, when using Z15.09, also report: code, if applicable, for any associated family history of the disease (Z80-Z84); code, if applicable, for any personal history of malignant neoplasm (Z85.-).
What SNOMED CT codes does Z15.09 map to?
Z15.09 maps to 19 SNOMED CT concepts: 765057007, 1186712009, 1186715006, 1172625004, 702411003, and 14 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for Z15.09?
Z15.09 is linked to 1 UMLS Concept Unique Identifier: C1455994. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does Z15.09 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like genetic susceptibility to other malignant neoplasm affect a person's functioning: body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of Z15.09?
There is no direct ICD-11 mapping available for Z15.09 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.